Poe-Jou Chen
Directeur Général chez Cali Biosciences Co. Ltd.
Profil
Poe-Jou Chen is currently the Chief Executive Officer & Executive Director at Cali Biosciences Co. Ltd.
and also holds the position of Chief Executive Officer & Director at Cali Shenzhen Biosciences Co. Ltd.
In the past, he worked as an Executive Director-Clinical Management at PPD Pharmaceuticals Research & Development Beijing Co. Ltd., Executive Director-Project Management at Wuxi Cds Clinical Research Shanghai Co. Ltd., Senior Vice President-Clinical Development at Aprinoia Therapeutics, Inc., and General Manager at Ubp Greater China Shanghai Co. Ltd.
Dr. Chen holds a graduate degree from Massachusetts Institute of Technology, a graduate degree from National Central University, and an undergraduate degree from National Tsing-Hua University.
Postes actifs de Poe-Jou Chen
| Sociétés | Poste | Début |
|---|---|---|
Cali Biosciences Co. Ltd.
 Cali Biosciences Co. Ltd. BiotechnologyHealth Technology Cali Biosciences Co. Ltd. operates as a biotechnology company dedicated to the research and development of new drugs for the perioperative space based on drug delivery platforms and other patented technologies. Its product focuses on non-opioid post-operative pain management, anti-inflammatory pain control, anesthesia, and sedation. The company was founded by Dibang Lin and Andrew Xian Chen on March 17, 2021 and is headquartered in Shenzhen, China. | Directeur Général | 17/03/2021 |
| Cali Shenzhen Biosciences Co. Ltd. | Directeur Général | - |
Anciens postes connus de Poe-Jou Chen
| Sociétés | Poste | Fin |
|---|---|---|
Aprinoia Therapeutics, Inc.
 Aprinoia Therapeutics, Inc. BiotechnologyHealth Technology Aprinoia Therapeutics, Inc. operates as a drug discovery and early development company. The company was founded by Ming-Kuei Jang in May 20, 2015 and is headquartered in Taipei, Taiwan. | Directeur Technique/Scientifique/R&D | 01/12/2020 |
| Ubp Greater China Shanghai Co. Ltd. | Corporate Officer/Principal | 01/11/2018 |
| PPD Pharmaceuticals Research & Development Beijing Co. Ltd. | Corporate Officer/Principal | 01/11/2016 |
| Wuxi Cds Clinical Research Shanghai Co. Ltd. | Corporate Officer/Principal | 01/06/2014 |
Formation de Poe-Jou Chen
| National Central University | Graduate Degree |
| Massachusetts Institute of Technology | Graduate Degree |
| National Tsing-Hua University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
 | Health Technology |
| Entreprise privées | 5 |
|---|---|
Cali Biosciences Co. Ltd.
Cali Biosciences Co. Ltd. BiotechnologyHealth Technology Cali Biosciences Co. Ltd. operates as a biotechnology company dedicated to the research and development of new drugs for the perioperative space based on drug delivery platforms and other patented technologies. Its product focuses on non-opioid post-operative pain management, anti-inflammatory pain control, anesthesia, and sedation. The company was founded by Dibang Lin and Andrew Xian Chen on March 17, 2021 and is headquartered in Shenzhen, China. | Health Technology |
| Cali Shenzhen Biosciences Co. Ltd. | |
| Ubp Greater China Shanghai Co. Ltd. | |
| PPD Pharmaceuticals Research & Development Beijing Co. Ltd. | |
| Wuxi Cds Clinical Research Shanghai Co. Ltd. |